Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor α tyrosine-phosphorylated peptide

Molecular Cancer Research

Volumn 5, Issue 11, 2007, Pages 1213-1221

  Varricchio, Lilian ^a   Migliaccio, Antimo ^a   Castoria, Gabriella ^a   Yamaguchi, Hiroshi ^b   De Falco, Antonietta ^a   Di Domenico, Marina ^a   Giovannelli, Pia ^a   Farrar, William ^c   Appella, Ettore ^b   Auricchio, Ferdinando ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLLEUCYLTYROSYLASPARTYLLEUCYLLEUCYLLEUCINAMIDE; ANDROGEN; CYCLIN D1; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTRADIOL RECEPTOR; ESTRADIOL RECEPTOR ALPHA; PEPTIDE; STEROID RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; SRC-FAMILY KINASES; TYROSINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 36249027472     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-0150     Document Type: Article

References (26)

1. Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med 2003;348:2431-2.
2. Peto R. Cancer, genes, and the environment. N Engl J Med 2000;343:1495-6.
3. Rosembaum Smith SM, Osborne MP. Breast cancer chemoprevention. Am J Surg 2000;180:249-51.
4. Migliaccio A, Pagano M, Auricchio F. Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene 1993;8:2183-91.
5. Migliaccio A, Di Domenico M, Castoria, et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996;15:1292-300.
6. Migliaccio A, Castoria G, Di Domenico M, et al. Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J 2000;19:5406-17.
7. Castoria G, Migliaccio A, Green S, Di Domenico M, Chambon P, Auricchio F. Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry 1993;32:1740-50.
8. Arnold SF, Obourn JD, Jaffe H, Notides AC. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro. J Biol Chem 1995;270:27489-94.
9. Castoria G, Migliaccio A, Bilancio A, et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 2001;20:6050-9.
10. Castoria G, Lombardi M, Barone MV, et al. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 2003;161:547-56.
11. 1/S progression of MCF-7 cells. Mol Cell Biol 2004;24:7643-53.
12. Enmark E, Pelto-Hikko M, Grandien K, et al. Human estrogen receptor β-gene structure, chromosomal localization and expression pattern. J Clin Endocrinol Metab 1997;82:4258-65.
13. Migliaccio A, Di Domenico M, Castoria G, et al. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Cancer Res 2005;65:10585-93.
14. Kousteni S, Bellido T, Plotkin LI, et al. Nongenotropic, sex-nonspecific signalling through the estrogen and androgen receptors: dissociation fron transcriptional activity. Cell 2001;104:719-30.
15. Fernando RI, Wimalasena J. Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signalling through Erk and Akt. Mol Biol Cell 2004;15:3266-84.
16. Veronesi U, Boyle P, Goldhirsch A, et al. Breast cancer. Lancet 2005;365:1727-41.
17. Castoria G, Barone MV, Di Domenico M, et al. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J 1999;18:2500-10.
18. Hennequin LF, Allen J, Breed J, et al. N-(5-chloro-1,3 benzodioxol-4-yl)-7-[2-(4-methyl-piperazin-1-yl)ethoxy]-5-(tetrahydro-2 H-pyran-4 yloxy) quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. J Med Chem 2006;49:6465-88.
19. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000;407:538-41.
20. Song RX, McPherson RA, Adam L, et al. Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol Endocrinol 2002;16:116-27.
21. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ. Estrogen receptor-interacting protein that modulates its nongenomic activity - crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci U S A 2002;99:14783-8.
22. Verrijdt G, Schoenmakers E, Haelens A, et al. Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. J Biol Chem 2000;275:12298-305.
23. Wang LH, Yang XY, Zhang X, et al. Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer. Cancer Cell 2006;10:487-99.
24. Wang LH, Yang XY, Zhang X, et al. Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor. Nat Med 2004;10:40-7.
25. Kaelin WG, Pallas DC, De Caprio, et al. Identification of cellular proteins that can interact with T/E1A-binding region of the retinoblastoma product. Cell 1991;64:521-32.
26. Migliaccio A, Piccolo D, Castoria G, et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 1998;17:2008-18.